| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799b6c8cb40ea97102dceda7bfe7b5c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2018-01-02^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f2dd388ff1e191ed66516b3fe993a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fe74f6ba723ea51e1c5056f023bdd7b |
| publicationDate |
2019-07-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190082571-A |
| titleOfInvention |
Pharmaceutical Anti-Tuberculosis Composition Comprising Sirt3 |
| abstract |
The present invention relates to an anti-tuberculosis pharmaceutical composition for inhibiting the growth of Mycobacterium tuberculosis by activating autophagy in macrophages and enhancing immune function during infection with tubercle bacilli, and more particularly, to an anti-tuberculosis pharmaceutical composition comprising Sirt3 (Sirtuin3) ≪ / RTI > |
| priorityDate |
2018-01-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |